Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Candesartan in Aortic Stenosis
NCT00699452Phase 3Unknown
- Sponsor
- University of Helsinki
- Start
- May 2009
- Primary completion
- Dec 2012
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of candesartan in aortic valve stenosis, sponsored by University of Helsinki. Status: unknown.
02
Drugs
candesartan
03
Conditions
aortic valve stenosis
Beyond the preview
Go deeper on NCT00699452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00699452.